Strumento inattivo

Azioni 20/20 GeneSystems Inc.

Azioni

Durata

Periodo

Stile

20/20 GeneSystems Inc. announced that it expects to receive $4.999995 million in funding	15/08/22
20/20 GeneSystems, Inc. Launches First Accelerator Facility for Innovative Clinical Lab Tests	28/09/21
20/20 GeneSystems, Inc. announced that it has received $2 million in funding	04/02/16
20/20 GeneSystems, Inc. announced that it expects to receive $3 million in funding.	28/01/16
20/20 GeneSystems, Inc. announced that it has received $4.5 million in funding from Ping An Ventures and other investors.	14/01/16

Dirigenti	Titolo	Età	Da
Jonathan Cohen CEO	Chief Executive Officer	-	01/01/08
Nora Li PRN	Corporate Officer/Principal	-	-

Amministratori	Titolo	Età	Da
Richard Cohen BRD	Director/Board Member	73	01/01/16
Jonathan Cohen CEO	Chief Executive Officer	-	01/01/08
John Compton BRD	Director/Board Member	-	-

Settore